Valuation: Bio-Techne Corporation

Capitalization 742.45Cr 633.23Cr 580.76Cr 549.73Cr 1.02TCr 71TCr 1.03TCr 6.92TCr 2.69TCr 34TCr 2.79TCr 2.73TCr 1,17100Cr P/E ratio 2026 *
40.7x
P/E ratio 2027 * 34.3x
Enterprise value 735.42Cr 627.24Cr 575.26Cr 544.52Cr 1.01TCr 70TCr 1.02TCr 6.85TCr 2.67TCr 33TCr 2.76TCr 2.7TCr 1,16000Cr EV / Sales 2026 *
6.08x
EV / Sales 2027 * 5.58x
Free-Float
99.69%
Yield 2026 *
0.67%
Yield 2027 * 0.67%
1 day+0.27%
1 week-16.34%
Current month-14.28%
1 month-14.62%
3 months-20.36%
6 months-22.77%
Current year-19.37%
1 week 46.42
Extreme 46.415
51
1 month 45.12
Extreme 45.115
62.47
Current year 45.12
Extreme 45.115
72.16
1 year 45.12
Extreme 45.115
72.16
3 years 45.12
Extreme 45.115
89.91
5 years 45.12
Extreme 45.115
135.96
10 years 23.92
Extreme 23.92
135.96
Manager TitleAgeSince
Chief Executive Officer 59 01/02/2024
Director of Finance/CFO 55 01/04/2014
Chief Tech/Sci/R&D Officer - 06/08/2023
Director TitleAgeSince
Chairman 70 02/11/2012
Director/Board Member 56 19/05/2009
Director/Board Member 63 26/10/2017
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-16.34%-12.02%-41.67% 742.45Cr
+0.27%-2.47%-16.97%-16.79% 4.33TCr
+1.39%+5.91%+35.08%+32.18% 3.45TCr
+1.09%-1.01%+247.95%+463.28% 3.06TCr
+0.87%-0.77%+12.12%-6.97% 2.9TCr
+1.05%-2.28%+27.24%+25.20% 2.73TCr
-0.43%+5.49% - - 1.48TCr
-3.59%-3.37%+113.03%+4,035.93% 1.35TCr
+0.60%+0.77%+126.16%+113.55% 1.25TCr
+1.16%+0.78%+5.45%-1.33% 1.21TCr
Average +0.27%-1.10%+59.78%+511.48% 2.25TCr
Weighted average by Cap. +0.51%+0.13%+58.24%+336.22%

Financials

2026 *2027 *
Net sales 120.92Cr 103.14Cr 95Cr 90Cr 165.93Cr 12TCr 167.52Cr 1.13TCr 438.71Cr 5.49TCr 453.76Cr 444.19Cr 19TCr 126.68Cr 108.05Cr 99Cr 94Cr 173.83Cr 12TCr 175.49Cr 1.18TCr 459.6Cr 5.75TCr 475.36Cr 465.34Cr 20TCr
Net income 18Cr 16Cr 14Cr 14Cr 25Cr 1.76TCr 26Cr 171.79Cr 67Cr 837.17Cr 69Cr 68Cr 2.91TCr 22Cr 19Cr 17Cr 16Cr 30Cr 2.11TCr 30Cr 205.05Cr 80Cr 999.23Cr 83Cr 81Cr 3.47TCr
Net Debt -7.03Cr -6Cr -5.5Cr -5.21Cr -9.65Cr -673.05Cr -9.74Cr -66Cr -26Cr -319.25Cr -26Cr -26Cr -1.11TCr -36Cr -31Cr -28Cr -27Cr -49Cr -3.44TCr -50Cr -334.46Cr -130.25Cr -1.63TCr -134.71Cr -131.87Cr -5.66TCr
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
Date Price Change Volume
12/26/12 47.42 $ 0.00% 17,67,193
11/26/11 47.42 $ -1.94% 27,06,682
08/26/08 48.36 $ -5.01% 38,50,168
07/26/07 50.91 $ +7.39% 51,47,270
06/26/06 47.40 $ -16.36% 1,19,48,713
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
47.42USD
Average target price
62.64USD
Spread / Average Target
+32.09%

Quarterly revenue - Rate of surprise